Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Alitel-MCH 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Alican Pharmaceutical Pvt Ltd

Salt Composition

Chlorthalidone (12.5mg) + Metoprolol Succinate (25mg) + Telmisartan (40mg)

Overview Alitel-MCH 25 Tablet ER

Aritel-25 Extended-Release tablets are a dual-action medication employed in managing hypertension. This formulation achieves blood pressure control by promoting vasodilation and optimizing cardiac output. It also facilitates diuresis, eliminating excess fluid and electrolytes. Aritel-25 ER may be administered with or without food, but consistent timing maximizes therapeutic efficacy. Due to its diuretic effect, daytime administration or at least four hours before sleep is recommended to minimize nocturnal urination. Dosage and frequency should strictly adhere to your physician's instructions, tailored to individual needs and condition severity. Continuous use, as prescribed, is crucial. Commonly reported adverse effects include nausea, altered taste perception, diarrhea, and gastrointestinal discomfort. Regular monitoring of renal function and electrolyte levels is essential. Optimal outcomes are achieved when combined with lifestyle modifications such as balanced nutrition, regular physical activity, and smoking cessation. Increased fluid intake is advised to counter potential dryness of the mouth or thirst. Prior to commencing treatment, inform your doctor of any pregnancy, circulatory disorders, hepatic or renal impairments, or concurrent medications, as drug interactions may compromise efficacy or alter the medication's effects.

Uses of Alitel-MCH 25 Tablet ER

Elevated blood pressure

Major Benefits of Alitel-MCH 25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Alitel-MCH 25 Tablet ER whole; avoid chewing, crushing, or fracturing it. This extended-release tablet can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Alitel-MCH 25 Tablet ER:

  • Nausea
  • Taste change
  • Diarrhea
  • Upset stomach
  • Headache
  • Dizziness
  • Weakness
  • Cold extremities
  • Numbness of extremity
  • Increased uric acid level in blood
  • Increased blood lipid level
  • Decreased magnesium level in blood
  • Slow heart rate
  • Decreased sodium level in blood
  • Decreased blood pressure

How to use Alitel-MCH 25 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not break, crush, or chew it. Alitel-MCH 25 Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.

How Alitel-MCH 25 Tablet ER works:

Alitel-MCH 25 Extended-Release tablets contain chlorthalidone, metoprolol succinate, and telmisartan, a triple drug formulation for effective blood pressure reduction.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Alitel-MCH 25 Tablet ER and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Alitel-MCH 25mg tablets pose a confirmed risk to the unborn child and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Alitel-MCH 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Taking Alitel-MCH 25 Extended-Release tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when prescribing Alitel-MCH 25 Tablet ER to individuals with severe renal impairment; dosage modification may be necessary. Physician consultation is advised. Alitel-MCH 25 Tablet ER is contraindicated in such cases.

LiverLiverCAUTION

Patients with hepatic impairment should use Alitel-MCH 25 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. Alitel-MCH 25 Tablet ER is contraindicated in individuals with severe liver disease.

What if you forget to take Alitel-MCH 25 Tablet ER :

Should you forget to take your Alitel-MCH 25 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Alitel-MCH 25 Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication HEART
Alitel-MCH 25 Tablet ER
80
MRP 98
18% off